The Lancet medical journal published an article on the high efficacy of the Sputnik Light vaccine – Topky.sk

The side effects of this vaccine in the vaccinees were mild to moderate in nature. The Sputnik Light single-dose vaccine is effective when given alone or as a booster dose. According to TASS, this vaccine is already registered in more than 15 countries and another 30 are in the process of being registered.

Sputnik Light contains recombinant adenovirus type 26, which transfers part of the genetic material of the SARS-CoV-2 coronavirus spike protein to the cells. The initial phase of testing took place in a facility in Russia and was financially covered by the Russian Direct Investment Fund (RFPI), the study said.

Data from the Gamalej Research Institute in Moscow based on a single dose of Sputnik Light to 28,000 people in Moscow showed that the vaccine had 70% efficacy against the coronavirus variant of delta at a single dose. This effectiveness will be maintained for three months. Sputnik Light was up to 75 percent effective in people under the age of 60.